• Explore /
  • Poster
  • / Final results from SAUL, a single-arm international real-world study of atezolizumab (atezo) in 1004 patients (pts) with pretreated locally advanced/metastatic urinary tract carcinoma (UTC).

Final results from SAUL, a single-arm international real-world study of atezolizumab (atezo) in 1004 patients (pts) with pretreated locally advanced/metastatic urinary tract carcinoma (UTC).

Abstract Poster

Authors

Cora Sternberg

Cora N. Sternberg

Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY

Cora N. Sternberg , Yohann Loriot , Ernest Choy , Daniel Castellano , Fernando Lopez-Rios Moreno , Giuseppe Luigi Banna , Ugo De Giorgi , Cristina Masini , Aristotelis Bamias , Xavier Garcia del Muro , Ignacio Duran , Thomas Powles , Marija Gamulin , Friedemann Zengerling , Lajos Geczi , Craig Gedye , Robert A Huddart , Geetha Kandula , Pari Skamnioti , Axel S. Merseburger

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Urothelial Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT02928406

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4569)

DOI

10.1200/JCO.2023.41.16_suppl.4569

Abstract #

4569

Poster Bd #

61

Abstract Disclosures

Similar Posters

First Author: Daniel Castellano

First Author: Cora N. Sternberg

First Author: Margitta Retz

First Author: Leisha A. Emens